Dublin, Aug. 24, 2021 (GLOBE NEWSWIRE) -- The "Circulating Tumor Cells Markets 2021-2027" report has been added to ResearchAndMarkets.com's offering. The global circulating tumor cells market size is expected to reach USD 18.3 billion by 2027, expanding at a CAGR of 11.7% from 2021 to 2027.
The University of California, Davis, set a new record for external research funding, receiving $968 million in awards in the fiscal year 2020-21, up $27 million from the previous record set last year. A major reason for this years growth was increased funding related to medicine and public health.
Krina K.
Circulating tumor cells (CTCs) are a blistering topic of oncological conferences and research due to their tremendous potential in the area of cancer diagnosis as well as treatment.
Prolymphocytic leukemia (PLL) is a very rare subtype of chronic leukemia. Although most forms of chronic leukemia progress slowly, PPL is often aggressive and can be difficult to treat.
Scientists Dr. Cristina Puig-Saus and Dr.
Senescent immune system cells are potentially among the most harmful of all senescent cells because they spread tissue damage and rapid aging across other body organs and systems. That is what a team of NIA-supported scientists at the University of Minnesota Medical School discovered through research using a mouse model that accelerated immune system aging by hindering DNA repair. The team recently published these findings in Nature.
Leukemia is a group of cancers that affect your bone marrow and cause your body to produce abnormal blood cells. Acute myeloid leukemia (AML) is the most common type of leukemia in adults and accounts for about 4 out of 5 adult cases. Acute monocytic leukemia (AML-M5) is a subtype of AML, in which at least 80 percent of the affected blood cells are a type of white blood cell called monocytes
Multiple sclerosis is an autoimmune disease that can affect the brain and spinal cord, and it is estimated that 130,000 people in the UK have the condition. There are drugs available to slow the onset of symptoms but treatment options for progressive MS are limited and there is currently no cure.
Aging-US published "PirB functions as an intrinsic suppressor in hippocampal neural stem cells" which reported that neural stem cells play pivotal roles during prenatal development and throughout life. PirB expression increased with age during development, and its deficiency promoted neural stem cell proliferation and differentiation in vivo and in vitro
Recent Comments